Nigmastudy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New Allakos Data Presented at DDW 2021 Suggest that Eosinophilic Gastritis and/or Eosinophilic Duodenitis (EG/EoD) is Highly Underdiagnosed and may be a Common Cause of Moderate-to-Severe Gastrointestinal Symptoms
45% (181/405) of patients with chronic functional gastrointestinal symptoms who underwent upper endoscopy with biopsy met the diagnostic criteria for eosinophilic gastritis and/or eosinophilic duodenitis (EG/EoD)
May 24, 2021 07:00 ET
| Source:
Allakos Inc.
Allakos Inc.
Redwood City, California, UNITED STATES
REDWOOD CITY, Calif., May 24, 2021 (GLOBE NEWSWIRE) Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast cell-related diseases, reported data at Digestive Disease Week (DDW) 2021. Results from a prospective study examined the rates of elevated tissue eosinophils in patients with chronic unex ....

United States , Anthony Lembo , Nicholas Talley , Global Research , Company Phase , Division Of Gastroenterology , Company Nasdaq , Professor Of Medicine At Harvard Medical School , University Of North Carolina At Chapel Hill , Hepatology Department Of Medicine , Allakos Inc , University Of Newcastle , Digestive Disease Week , Associate Professor , Harvard Medical , Pro Vice Chancellor , Adjunct Professor , Hepatology Department , North Carolina , Prevalence Study , Eosinophilic Gastritis , New England Journal , Nasdaq Allk , Allakos Inc , ஒன்றுபட்டது மாநிலங்களில் , அந்தோணி லெம்போ ,